ACTRN12608000382370终止2 期
A Randomised Phase II Trial to evaluate the response of Weekly Docetaxel (Taxotere) Chemoradiotherapy +/- Cetuximab (Erbitux) for Localised Resectable Cancer of the Oesophagus
Australasian Gastro-Intestinal Trials Group (AGITG)0 个研究点目标入组 80 人开始时间: 2008年8月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Adenocarcinoma of the oesophagus or oesophago-gastric junction, suitable for definitive surgical resection.
- •Eastern Cooperative Oncology Group (ECOG) performance status 0-1.
排除标准
- •Distant visceral or nodal metastases.
- •Previous chemotherapy or radiotherapy for oesophageal cancer.
- •Carcinoma of the cervical oesophagus, or tumour predominantly in the stomach.
研究者
相似试验
招募中
2 期
A study to evaluate the role of modified regular interval based combined oral chemotherapy that regresses tumor cell development of various forms which is indicated for the treatment of High-Risk Medulloblastoma (a type of brain tumor)CTRI/2019/09/021213TMC Research Administration Council
进行中（未招募）
1 期
Clinical Study Evaluating the immune responses and safety of single versus two dose COVID-19 mRNA Vaccination in children (CoVacc)Healthy volunteers (paediatric subjects) with prior SARS-CoV-2 infectionMedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 100000004865EUCTR2021-005043-71-DEniversity Medical Center Utrecht200
进行中（未招募）
1 期
Clinical Study Evaluating the immune responses and safety of single versus two dose COVID-19 mRNA Vaccination in children (CoVacc)Healthy volunteers (paediatric subjects) with prior SARS-CoV-2 infectionMedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2021-005043-71-NOniversity Medical Center Utrecht200
进行中（未招募）
1 期
Immunogenicity and reactogenicity of reduced COVID-19 vaccination regimen in children (CoVacc).Healthy volunteers (paediatric subjects) with prior SARS-CoV-2 infectionMedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 100000004865EUCTR2021-005043-71-GRniversity Medical Center Utrecht200
进行中（未招募）
1 期
Clinical Study Evaluating the immune responses and safety of single versus two dose COVID-19 mRNA Vaccination in children (CoVacc)Healthy volunteers (paediatric subjects) with prior SARS-CoV-2 infectionMedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 100000004865EUCTR2021-005043-71-SEniversity Medical Center Utrecht200